The nonsignificant difference in CK5/6 positivity between the tumor subtypes (43.4 %, 27.7 %, 62.5 %, and 55.6 % for Hormonal, Dual, HER2, and TN tumors, respectively) in this study may explain this finding. Here, ERBB2 is linked to neoplasm.